Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $8.46 | $8.37 | -1.06% | 0.3M |
| 05-12 | $8.41 | $8.41 | +0.00% | 0.6M |
| 05-13 | $8.27 | $8.21 | -0.73% | 0.4M |
| 05-14 | $8.25 | $8.61 | +4.36% | 0.2M |
| 05-15 | $8.44 | $8.55 | +1.36% | 0.1M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Annual 2018 2018-12-31 | Q3 2018 2018-09-30 | Q2 2018 2018-06-30 | Q1 2018 2018-03-31 |
|---|---|---|---|---|
Revenue | $10.55M | $7.33M | $4.42M | $2.06M |
Operating Income | $415.00K | $289.00K | $384.00K | $588.00K |
Net Income | $-1.09M | $-820.00K | $-301.00K | $204.00K |
EPS (Diluted) | $-0.05 | $-0.04 | $-0.01 | $0.01 |
Total Assets | $64.07M | $63.99M | $63.52M | $64.97M |
Total Liabilities | $43.63M | Not available | Not available | Not available |
Cash & Equivalents | $4.32M | $3.88M | $2.36M | $1.53M |
Free Cash Flow OCF − CapEx | $11.11M | $3.69M | $2.10M | $-67.00K |
Shares Outstanding | 19.58M | 19.57M | 22.45M | 22.77M |
No sell-side coverage available for INFU.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for INFU.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.